Korsana Biosciences (KRSA) Non Operating Income (2019 - 2026)
Korsana Biosciences' Non Operating Income came in at $30,000 for Q3 2025, down 92.6% from $405,000 a year earlier and down 97.8% from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) Non Operating Income (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Korsana Biosciences reported Non Operating Income of $1.43 million, up 122.7% year-over-year; for FY2024, it was $571,000, up 59.5% from FY2023.
- Non Operating Income carries a four-year compound annual growth rate of -0.7% (FY2020 to FY2024).
- Going back by year, Non Operating Income was $358,000 in FY2023 (+21.8%), $294,000 in FY2022, -$16,000 in FY2021 and $588,000 in FY2020.
- The five-year range for quarterly Non Operating Income is -$6,000 (Q2 2021) to $1.35 million (Q2 2025).
- Year-over-year, Non Operating Income increased in 1 of the last seven quarters, with growth averaging 1.9%.
- The fastest year-over-year change in Non Operating Income over five years came in Q3 2024 (growth of 278.5%), and the weakest in Q3 2025 (a decline of 92.6%).
- Business Quant data shows KRSA's Non Operating Income at $1.35 million (Q2 2025), $28,000 (Q1 2025) and $28,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Korsana Biosciences | 1.42 Bn | 802.23 Mn | - | 1,849.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1,849.00 |
| Jun 30, 2026 | 16,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 234.00 |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 76,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | 107,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Mar 31, 2023 | 88,000.00 |
| Dec 31, 2022 | 132,000.00 |
| Sep 30, 2022 | 111,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | -1,000.00 |
API Access
Korsana Biosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();